silybin has been researched along with Carcinoma, Anaplastic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barba, FJ; Barth, D; Ben Rahal, N; Chevalot, I | 1 |
| Agarwal, R; Singh, RP; Tyagi, A; Velmurugan, B | 1 |
| Agarwal, C; Agarwal, R; Deep, G; Katiyar, S; Kaur, M; Tyagi, A; Velmurugan, B | 1 |
| Agarwal, R; Gu, M; Ravichandran, K; Singh, RP; Velmurugan, B | 1 |
| Agarwal, R; Singh, RP | 1 |
| Agarwal, C; Agarwal, R; Deep, G; Kroll, DJ; Singh, RP | 1 |
| Comelli, MC; Mengs, U; Prosdocimi, M; Schneider, C | 1 |
2 review(s) available for silybin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Mechanisms and preclinical efficacy of silibinin in preventing skin cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Communication; Cell Cycle; Cell Proliferation; Dermatitis; DNA Damage; Humans; Mice; Mitogens; Silybin; Silymarin; Skin Neoplasms; Tumor Suppressor Protein p53; Ultraviolet Rays | 2005 |
Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Carcinoma; Cytoprotection; Humans; Liver; Liver Diseases; Male; Oxidative Stress; Prostatic Neoplasms; Protein Kinase Inhibitors; Receptors, Growth Factor; Silybin; Silymarin; Transcription Factors; Tumor Necrosis Factor-alpha | 2007 |
5 other study(ies) available for silybin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Supercritical CO₂ extraction of oil, fatty acids and flavonolignans from milk thistle seeds: Evaluation of their antioxidant and cytotoxic activities in Caco-2 cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Caco-2 Cells; Carcinoma; Cell Survival; Chromatography, Supercritical Fluid; Dietary Supplements; Fatty Acids; Flavonolignans; Food Additives; Humans; Plant Oils; Seeds; Silybin; Silybum marianum; Silymarin; Tunisia | 2015 |
Inhibition of azoxymethane-induced colonic aberrant crypt foci formation by silibinin in male Fisher 344 rats.
Topics: Animals; Antineoplastic Agents; Azoxymethane; Carcinogens; Carcinoma; Colonic Neoplasms; Cyclin D1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Intestinal Mucosa; Male; Nitric Oxide Synthase Type II; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats; Rats, Inbred F344; Silybin; Silymarin | 2008 |
Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Cycle Proteins; Cell Death; Colorectal Neoplasms; Humans; Male; Mice; Mice, Nude; Silybin; Silymarin; Xenograft Model Antitumor Assays | 2009 |
Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice.
Topics: Angiogenic Proteins; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Azoxymethane; Carcinogens; Carcinoma; Cell Proliferation; Colonic Neoplasms; Cytoprotection; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Inflammation Mediators; Male; Mice; Mice, Inbred Strains; Silybin; Silymarin | 2010 |
Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Topics: Carcinoma; Cell Cycle; Cell Cycle Proteins; Cell Nucleus; Cell Proliferation; Cyclin-Dependent Kinases; Cytoplasm; Flavones; Humans; Male; Phosphorylation; Prostatic Neoplasms; Silybin; Silymarin; Tumor Cells, Cultured | 2006 |